Genmab A/S (GMAB) Reports 2022 Net Sales of DARZALEX of $7.98B

Go back to Genmab A/S (GMAB) Reports 2022 Net Sales of DARZALEX of $7.98B
(NASDAQ: GMAB) Delayed: 32.96 +0.12 (0.37%)
Previous Close $32.84    52 Week High
Open $32.86    52 Week Low
Day High $33.11    P/E N/A 
Day Low $32.66    EPS
Volume 2,706,951